DoD Says AVI Biopharma's (AVII) Flu Drug Candidate Does Not Qualify for Contract Award

October 14, 2011 8:38 AM EDT Send to a Friend
Get Alerts AVII Hot Sheet
Trade AVII Now!
Join SI Premium – FREE
AVI Biopharma (Nasdaq: AVII) receives notice from Department of Defense its proposal for full clinical development of its influenza candidate, AVI-7100 did not qualify for a contract award.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News

Add Your Comment